Globus' sales soar in Q2; Hologic wins FDA nod for imaging tech;

@FierceMedDev: Trending on FierceMedicalDevices.com: Covidien watches profits slide after kicking drugs. Article | Follow @FierceMedDev

@MarkHFierce: House Republican freshmen are pressing hard for a vote on a device tax repeal bill. Item | Follow @MarkHFierce

@DamianFierce: Now the Senate is getting in on the push to spare FDA user fees from sequester cuts. Story | Follow @DamianFierce

@MichaelGFierce: Trending on FierceDrugDelivery.com: Swedish team creates 'impossible' record-breaking drug delivery material. Article | Follow @MichaelGFierce

> Globus Medical ($GMED) hauled in $107 million in revenue last quarter, 11.5% above the same period last year. Results

> Ambry Genetics has launched sequencing-based renal, pancreatic and paraganglioma-pheochromocytoma cancer tests. News

> Hologic ($HOLX) picked up FDA clearance for its dual energy X-ray absorptiometry femur exam. More

> Illumina's ($ILMN) Verinata Health became the first non-invasive prenatal test provider to win a clinical lab permit from the New York State Department of Health. Release

> Finnish outfit Biohit has launched a test that detect celiac disease, ditching endoscopy and using only fingertip blood. Article

> As concerns mount over how life sciences companies conduct themselves in China, Baxter ($BAX) revealed that it encountered bribery in one of its joint ventures there but has dealt with the issue internally. Report | More from FiercePharma

> Diagnostics developer Castle Biosciences notched more positive data for its DecisionDx-Melanoma test, demonstrating that the gene-expression assay is an effective tool for classifying which cancers will recur. Item

Biotech News

@FierceBiotech: Industry Voices: The Zero-Person Biotech Company. Item | Follow @FierceBiotech

@JohnCFierce: Biotech's IPO boom extends its streak through a blistering July. Report | Follow @JohnCFierce

@RyanMFierce: Didn't take the lawyers long to start fishing for angry Optimer shareholders after Cubist buyout announced Tuesday. Release | Follow @RyanMFierce

@EmilyMFierce: NIH team sees diabetes drug as a possible tool for extending life. Story | Follow @EmilyMFierce

> Survey: Americans say cancer should be top priority for medical research. Story

> Stem cell transplants show potential in patients with extremely rare brain disease. More

> Baxter caught up in China bribery scandal. Item

Pharma News

@FiercePharma: Tension rises for pharma in China as court reportedly fines J&J, officials visit Sanofi. ICYMI yesterday | Follow @FiercePharma

@CarlyHFierce: More bribery allegations in China, these ones against Baxter (and just now surfacing from last year). News | Follow @CarlyHFierce

> 'Brazil generics issue' costs Sanofi nearly as much as patent losses. News

> Indian challenge to GSK's Tykerb comes from Fresenius. Article

> Teva earnings come up short and path to future rockier than before. Story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.